J. David Knight

2.1k total citations · 1 hit paper
22 papers, 1.5k citations indexed

About

J. David Knight is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Economics and Econometrics. According to data from OpenAlex, J. David Knight has authored 22 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 11 papers in Surgery and 7 papers in Economics and Econometrics. Recurrent topics in J. David Knight's work include Acute Myocardial Infarction Research (10 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Heart Failure Treatment and Management (6 papers). J. David Knight is often cited by papers focused on Acute Myocardial Infarction Research (10 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Heart Failure Treatment and Management (6 papers). J. David Knight collaborates with scholars based in United States, Canada and Poland. J. David Knight's co-authors include Michael B. Higginbotham, Michael Sullivan, Frederick R. Cobb, Daniel B. Mark, Nancy E. Clapp‐Channing, Eric J. Topol, Kerry L. Lee, Paul W. Armstrong, Charlotte Nelson and C. David Naylor and has published in prestigious journals such as New England Journal of Medicine, Circulation and Annals of Internal Medicine.

In The Last Decade

J. David Knight

22 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure.

1989 414 citations Michael Sullivan, J. David Knight et al. Circulation profile →

Peers

Countries citing papers authored by J. David Knight

Since Specialization

Citations

This map shows the geographic impact of J. David Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. David Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. David Knight more than expected).

Fields of papers citing papers by J. David Knight

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. David Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. David Knight. The network helps show where J. David Knight may publish in the future.

Co-authorship network of co-authors of J. David Knight

This figure shows the co-authorship network connecting the top 25 collaborators of J. David Knight. A scholar is included among the top collaborators of J. David Knight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. David Knight. J. David Knight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery 2019 ·Journal of Thoracic and Cardiovascular Surgery ·Sean van Diepen, Rajendra H. Mehta, Jeffrey D. Leimberger, Shaun G. Goodman, Stephen E. Fremes, Rachael Jankowich, Matthias Heringlake, Kevin J. Anstrom, Jerrold H. Levy, John M. Luber, A. Dave Nagpal, Andra E. Duncan, Michael Argenziano, Wolfgang Toller, Kevin Teoh, J. David Knight, Renato D. Lópes, Patricia A. Cowper, Daniel B. Mark, John H. Alexander	29
2	Acute and 1‐Year Hospitalization Costs for Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention: Results From the TRANSLATE‐ACS Registry 2019 ·Journal of the American Heart Association ·Patricia A. Cowper, J. David Knight, Linda Davidson‐Ray, Eric D. Peterson, Tracy Y. Wang, Daniel B. Mark, (unknown)	46
3	Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure 2018 ·Journal of the American College of Cardiology ·Daniel B. Mark, Patricia A. Cowper, Kevin J. Anstrom, Shubin Sheng, Melanie R. Daniels, J. David Knight, Khaula Baloch, Linda Davidson‐Ray, Mona Fiuzat, James L. Januzzi, David J. Whellan, Ileana L. Piña, Justin A. Ezekowitz, Kirkwood F. Adams, Lawton S. Cooper, Christopher M. O’Connor, G. Michael Felker	19
4	Health-related quality of life outcomes with prasugrel among medically managed non–ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial 2016 ·American Heart Journal ·Padma Kaul, E. Magnus Ohman, J. David Knight, Kevin J. Anstrom, Matthew T. Roe, William E. Boden, Judith S. Hochman, Vladimir Gašparović, Paul W. Armstrong, Patrick L. McCollam, (unknown), Patricia A. Cowper, Linda Davidson‐Ray, Nancy E. Clapp‐Channing, Harvey D. White, Keith A.A. Fox, Dorairaj Prabhakaran, Daniel B. Mark	3
5	Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease 2016 ·Annals of Internal Medicine ·Daniel B. Mark, Jerome J. Federspiel, Patricia A. Cowper, Kevin J. Anstrom, Udo Hoffmann, Manesh R. Patel, Linda Davidson‐Ray, Melanie R. Daniels, Lawton S. Cooper, J. David Knight, Kerry L. Lee, Pamela S. Douglas, (unknown)	43
6	Quality-of-Life Outcomes With a Disodium EDTA Chelation Regimen for Coronary Disease 2014 ·Circulation Cardiovascular Quality and Outcomes ·Daniel B. Mark, Kevin J. Anstrom, Nancy E. Clapp‐Channing, J. David Knight, Robin Boineau, Christine Goertz, Theodore Rozema, (unknown), Richard L. Nahin, Yves Rosenberg, Jeanne Drisko, Kerry L. Lee, Gervasio A. Lamas	4
7	Quality-of-Life Outcomes With Coronary Artery Bypass Graft Surgery in Ischemic Left Ventricular Dysfunction 2014 ·Annals of Internal Medicine ·Daniel B. Mark, J. David Knight, Eric J. Velazquez, Jarosław Wasilewski, Jonathan G. Howlett, Peter K. Smith, John A. Spertus, Miroslaw Rajda, Rakesh Yadav, Baron L. Hamman, Marcin Malinowski, Ajay Naik, (unknown), Tina Harding, Laura Drew, Patrice Desvigne‐Nickens, Kevin J. Anstrom	41
8	Surgical Treatment of Ischemic Heart Failure Trial 2011 ·Journal of Cardiac Failure ·Daniel B. Mark, J. David Knight, Eric J. Velazquez, Jarosław Wasilewski, Jonathan G. Howlett, Peter K. Smith, Miroslaw Rajda, Rakesh Yadav, Baron L. Hamman, Marcin Malinowski, (unknown), (unknown), Tina Harding, Laura Drew, Patrice Desvigne‐Nickens, Kevin J. Anstrom	1
9	Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: Results from the Surgical Treatment for Ischemic Heart Failure trial 2009 ·American Heart Journal ·Daniel B. Mark, J. David Knight, Eric J. Velazquez, Jonathan G. Howlett, John A. Spertus, (unknown), Tina Harding, (unknown), Laura Drew, Bożena Szyguła‐Jurkiewicz, Christopher Adlbrecht, Kevin J. Anstrom	25
10	Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: Results from the Treating to New Targets (TNT) Trial 2008 ·American Heart Journal ·Daniel B. Mark, J. David Knight, Patricia A. Cowper, Linda Davidson‐Ray, Kevin J. Anstrom	31
11	Impact of rate-modulated pacing on quality of life and exercise capacity—Evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT) 2007 ·Heart Rhythm ·Gervasio A. Lamas, J. David Knight, Michael O. Sweeney, Marcus Mianulli, (unknown), Koroush Khalighi, James R. Cook, (unknown), Lawrence Rosenthal, Nancy E. Clapp‐Channing, Kerry L. Lee, Daniel B. Mark	54
12	Development and validation of a simple model to predict severe coronary artery disease after myocardial infarction: Potential impact on cardiac catheterization use in the United States and Canada 2003 ·American Heart Journal ·Wayne Batchelor, Daniel B. Mark, J. David Knight, Christopher B. Granger, Paul W. Armstrong, Robert M. Califf, Eric D. Peterson	4
13	Economic Assessment of Platelet Glycoprotein IIb/IIIa Receptor Blockade With Abciximab and Low-Dose Heparin During Percutaneous Coronary Revascularization 2000 ·Circulation ·A. Michael Lincoff, Daniel B. Mark, James E. Tcheng, Robert M. Califf, Mohan Bala, Keaven M. Anderson, Linda Davidson‐Ray, J. David Knight, Catherine F. Cabot, Eric J. Topol	25
14	Evaluating the Potential ???Economic Attractiveness??? of New Therapies in Patients with Non-ST Elevation Acute Coronary Syndrome 2000 ·PharmacoEconomics ·Eric L. Eisenstein, Eric D. Peterson, James G. Jollis, Barbara E. Tardiff, Robert M. Califf, J. David Knight, Daniel B. Mark	20
15	Assessing the Value of Newer Pharmacologic Agents in Non-ST Elevation Patients: A Decision Support System Application 1997 ·Journal of the American Medical Informatics Association ·Eric L. Eisenstein, Eric D. Peterson, James G. Jollis, Barbara E. Tardiff, Robert M. Califf, J. David Knight, Daniel B. Mark	3
16	Assessing the value of newer pharmacologic agents in non-ST elevation patients: a decision support system application. 1997 ·PubMed ·Eric L. Eisenstein, Eric D. Peterson, James G. Jollis, Barbara E. Tardiff, Robert M. Califf, J. David Knight, Daniel B. Mark	3
17	Baseline and 6-month costs of primary angioplasty therapy for acute myocardial infarction: Results from the primary angioplasty registry 1995 ·Journal of the American College of Cardiology ·Daniel B. Mark, William W. O’Neill, Bruce R. Brodie, Russell J. Ivanhoe, William D. Knopf, George J. Taylor, James H. O’Keefe, Cindy L. Grines, Linda Davidson‐Ray, J. David Knight, Robert M. Califf	18
18	Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial Infarction 1995 ·New England Journal of Medicine ·Daniel B. Mark, Mark A. Hlatky, Robert M. Califf, C. David Naylor, Kerry L. Lee, Paul W. Armstrong, Gabriel I. Barbash, H. E. White, Maarten L. Simoons, Charlotte Nelson, Nancy E. Clapp‐Channing, J. David Knight, Frank E. Harrell, John Simes, Eric J. Topol	416
19	Use of Medical Resources and Quality of Life after Acute Myocardial Infarction in Canada and the United States 1994 ·New England Journal of Medicine ·Daniel B. Mark, C. David Naylor, Mark A. Hlatky, Robert M. Califf, Eric J. Topol, Christopher B. Granger, J. David Knight, Charlotte Nelson, Kerry L. Lee, Nancy E. Clapp‐Channing, W.H. Sutherland, Louise Pilote, Paul W. Armstrong	257
20	Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. breakdown → 1989 ·Circulation ·Michael Sullivan, J. David Knight, Michael B. Higginbotham, Frederick R. Cobb	414

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact